Lisa W. Martin

ORCID: 0000-0003-4352-0914
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genetic Associations and Epidemiology
  • Metabolomics and Mass Spectrometry Studies
  • Menopause: Health Impacts and Treatments
  • Cardiovascular Health and Risk Factors
  • Nutritional Studies and Diet
  • Estrogen and related hormone effects
  • Genomics and Rare Diseases
  • Lipoproteins and Cardiovascular Health
  • Vitamin D Research Studies
  • Nutrition, Genetics, and Disease
  • Birth, Development, and Health
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Health and Mental Health
  • RNA modifications and cancer
  • Heart Failure Treatment and Management
  • Bioinformatics and Genomic Networks
  • Lipid metabolism and disorders
  • Physical Activity and Health
  • Acute Myocardial Infarction Research
  • Obesity, Physical Activity, Diet
  • Cancer survivorship and care
  • Cardiovascular Function and Risk Factors
  • Cancer, Lipids, and Metabolism
  • Blood Pressure and Hypertension Studies
  • Cholesterol and Lipid Metabolism

George Washington University
2016-2025

Cincinnati Children's Hospital Medical Center
2013-2025

Northwestern University
2011-2024

University of Washington
2012-2024

Princeton University
1998-2023

Cambridge University Press
2023

Seattle University
2022

Beth Israel Deaconess Medical Center
2021

Nationwide Children's Hospital
2021

University of the Sunshine Coast
2021

Menopausal hormone therapy continues in clinical use but questions remain regarding its risks and benefits for chronic disease prevention.To report a comprehensive, integrated overview of findings from the 2 Women's Health Initiative (WHI) trials with extended postintervention follow-up.A total 27,347 postmenopausal women aged 50 to 79 years were enrolled at 40 US centers.Women an intact uterus received conjugated equine estrogens (CEE; 0.625 mg/d) plus medroxyprogesterone acetate (MPA; 2.5...

10.1001/jama.2013.278040 article EN JAMA 2013-10-01

Tamoxifen and raloxifene have limited patient acceptance for primary prevention of breast cancer. Aromatase inhibitors prevent more contralateral cancers cause fewer side effects than tamoxifen in patients with early-stage cancer.In a randomized, placebo-controlled, double-blind trial exemestane designed to detect 65% relative reduction invasive cancer, eligible postmenopausal women 35 years age or older had at least one the following risk factors: 60 older; Gail 5-year score greater 1.66%...

10.1056/nejmoa1103507 article EN New England Journal of Medicine 2011-06-04

The Women's Health Initiative Estrogen-Alone Trial was stopped early after a mean of 7.1 years follow-up because an increased risk stroke and little likelihood altering the balance to benefit by planned trial termination date. Postintervention health outcomes have not been reported.

10.1001/jama.2011.382 article EN JAMA 2011-04-05

By contrast with many observational studies, women in the Women's Health Initiative (WHI) trial who were randomly allocated to receive oestrogen alone had a lower incidence of invasive breast cancer than did those received placebo. We aimed assess influence use on longer term and mortality extended follow-up this cohort.Between 1993 1998, WHI enrolled 10,739 postmenopausal from 40 US clinical centres into randomised, double-masked, placebo-controlled trial. Women aged 50-79 years undergone...

10.1016/s1470-2045(12)70075-x article EN cc-by-nc-nd The Lancet Oncology 2012-03-07

Although studies have shown that physically active breast cancer survivors lower all-cause mortality, the association between change in physical activity from before to after diagnosis and mortality is not clear. We examined associations among pre- postdiagnosis activity, cancer-specific postmenopausal women. A longitudinal study of 4,643 women diagnosed with invasive entry into Women's Health Initiative Physical recreation walking was determined at baseline (prediagnosis) (assessed 3 or 6...

10.1158/1940-6207.capr-10-0295 article EN Cancer Prevention Research 2011-04-01

Framingham-based and Reynolds Risk scores for cardiovascular disease (CVD) prediction have not been directly compared in an independent validation cohort. We selected a case-cohort sample of the multiethnic Women's Health Initiative Observational Cohort, comprising 1722 cases major CVD (752 myocardial infarctions, 754 ischemic strokes, 216 other deaths) random subcohort 1994 women without prior CVD. estimated risk using Adult Treatment Panel III (ATP-III) score, Score, Framingham model,...

10.1161/circulationaha.111.075929 article EN Circulation 2012-03-08
Pierrick Wainschtein Deepti Jain Zhili Zheng Stella Aslibekyan Diane M. Becker and 95 more Wenjian Bi Jennifer A. Brody Jenna C. Carlson Adolfo Correa Margaret Mengmeng Du Lindsay Fernández‐Rhodes Kendra Ferrier Misa Graff Xiuqing Guo Jiang He Nancy L. Heard‐Costa Heather M. Highland Joel N. Hirschhorn Candace M Howard-Claudio Carmen R. Isasi Rebecca D. Jackson Jicai Jiang Roby Joehanes Anne E. Justice Rita R. Kalyani Sharon L. R. Kardia Ethan M. Lange Meryl S. LeBoff Seunggeun Lee Xihao Li Zilin Li Elise Lim D. Y. Lin Xihong Lin Simin Liu Yingchang Lu JoAnn E. Manson Lisa W. Martin Caitlin McHugh Julie Mikulla Solomon K. Musani Maggie Ng Deborah A. Nickerson Nicholette D. Palmer James A. Perry Ulrike Peters Michael Preuß Qibin Qi Laura M. Raffield Laura J. Rasmussen‐Torvik Alex P. Reiner Emily M. Russell Colleen M. Sitlani Jennifer A. Smith Cassandra N. Spracklen Tao Wang Zhe Wang Jennifer Wessel Hanfei Xu Mohammad Yaser Sachiko Yoneyama Kendra A. Young Jingwen Zhang Xinruo Zhang Hufeng Zhou Xiaofeng Zhu Sebastian Zoellner Namiko Abe Gonçalo R. Abecasis François Aguet Laura Almasy Álvaro Alonso Seth A. Ament Peter Anderson Pramod Anugu Deborah Applebaum‐Bowden Kristin Ardlie Dan E. Arking Allison E. Ashley‐Koch Tim Assimes Paul L. Auer Dimitrios Avramopoulos Najib Ayas Adithya Balasubramanian John Barnard Kathleen C. Barnes R. Graham Barr Emily Barron‐Casella Lucas Barwick Terri H. Beaty Gerald J. Beck Lewis C. Becker Rebecca Beer Amber L. Beitelshees Emelia J. Benjamin Takis Benos Marcos Bezerra Larry Bielak Joshua C. Bis Thomas W. Blackwell

10.1038/s41588-021-00997-7 article EN Nature Genetics 2022-03-01
Xihao Li Zilin Li Hufeng Zhou Sheila M. Gaynor Yaowu Liu and 95 more Han Chen Ryan Sun Rounak Dey Donna K. Arnett Stella Aslibekyan Christie M. Ballantyne Lawrence F. Bielak John Blangero Eric Boerwinkle Donald W. Bowden Jai Broome Matthew P. Conomos Adolfo Correa L. Adrienne Cupples Joanne E. Curran Barry I. Freedman Xiuqing Guo George Hindy Marguerite R. Irvin Sharon L. R. Kardia Sekar Kathiresan Alyna Khan Charles Kooperberg Cathy C. Laurie X. Shirley Liu Michael C. Mahaney Ani Manichaikul Lisa W. Martin Rasika A. Mathias Stephen T. McGarvey Braxton D. Mitchell May E. Montasser Jill E. Moore Alanna C. Morrison Jeffrey R. O’Connell Nicholette D. Palmer Akhil Pampana Juan M. Peralta Patricia A. Peyser Bruce M. Psaty Susan Redline Kenneth Rice Stephen S. Rich Jennifer A. Smith Hemant K. Tiwari Michael Y. Tsai Ramachandran S. Vasan Fei Fei Wang Daniel E. Weeks Zhiping Weng James G. Wilson Lisa R. Yanek Namiko Abe Gonçalo R. Abecasis François Aguet Christine M. Albert Laura Almasy Álvaro Alonso Seth A. Ament Peter Anderson Pramod Anugu Deborah Applebaum‐Bowden Kristin Ardlie Dan Arking Donna K. Arnett Allison E. Ashley‐Koch Stella Aslibekyan Tim Assimes Paul L. Auer Dimitrios Avramopoulos John Barnard Kathleen C. Barnes R. Graham Barr Emily Barron‐Casella Lucas Barwick Terri Beaty Gerald J. Beck Diane M. Becker Lewis C. Becker Rebecca Beer Amber L. Beitelshees Emelia J. Benjamin Takis Benos Marcos Bezerra Lawrence F. Bielak Joshua C. Bis Thomas W. Blackwell John Blangero Eric Boerwinkle Donald W. Bowden Russell P. Bowler Jennifer A. Brody Ulrich Broeckel Jai Broome Karen Bunting

10.1038/s41588-020-0676-4 article EN Nature Genetics 2020-08-24
Leslie A. Lange Youna Hu He Zhang Chenyi Xue Ellen M. Schmidt and 95 more Zheng-Zheng Tang Chris Bizon Ethan M. Lange Joshua D. Smith Emily H. Turner Goo Jun Hyun Min Kang Gina M. Peloso Paul L. Auer Kuo-ping Li Jason Flannick Ji Zhang Christian Fuchsberger Kyle J. Gaulton Cecilia M. Lindgren Adam E. Locke Alisa K. Manning Xueling Sim Manuel A. Rivas Oddgeir L. Holmen Omri Gottesman Yingchang Lu Douglas M. Ruderfer Eli A. Stahl Qing Duan Yun Li Peter Durda Shuo Jiao Aaron Isaacs Albert Hofman Joshua C. Bis Adolfo Correa Michael Griswold Jóhanna Jakobsdóttir Albert V. Smith Pamela J. Schreiner Mary F. Feitosa Qunyuan Zhang Jennifer E. Huffman Jacy R. Crosby Christina L. Wassel Ron Do Nora Franceschini Lisa W. Martin Jennifer G. Robinson Themistocles L. Assimes David R. Crosslin Elisabeth A. Rosenthal Michael Y. Tsai Mark J. Rieder Deborah Farlow Aaron R. Folsom Thomas Lumley Ervin R. Fox Christopher S. Carlson Ulrike Peters Rebecca D. Jackson Cornelia M. van Duijn André G. Uitterlinden Daniel Levy Jerome I. Rotter Herman A. Taylor Vilmundur Guðnason David S. Siscovick Myriam Fornage Ingrid B. Borecki Caroline Hayward Igor Rudan Y. Eugene Chen Erwin P. Böttinger Ruth J. F. Loos Pål Sætrom Kristian Hveem Michael Boehnke Leif Groop Mark I. McCarthy Thomas Meitinger Christie M. Ballantyne Stacey Gabriel Christopher J. O’Donnell Wendy S. Post Kari E. North Alexander P. Reiner Eric Boerwinkle Bruce M. Psaty David Altshuler Sekar Kathiresan Dan-Yu Lin Gail P. Jarvik L. Adrienne Cupples Charles Kooperberg James G. Wilson Deborah A. Nickerson Gonçalo R. Abecasis Stephen S. Rich

10.1016/j.ajhg.2014.01.010 article EN publisher-specific-oa The American Journal of Human Genetics 2014-02-01

Heart failure is an important and growing public health problem in women. Risk factors for incident hospitalized heart with preserved ejection fraction (HFpEF) compared reduced (HFrEF) women differences by race/ethnicity are not well characterized.

10.1161/circheartfailure.115.002883 article EN Circulation Heart Failure 2016-09-29

Current dietary recommendations for patients with heart failure (HF) are largely based on data from non-HF populations; evidence associations of patterns outcomes in HF is limited. We therefore evaluated Mediterranean and Dietary Approaches to Stop Hypertension (DASH) diet scores mortality among postmenopausal women HF. Women's Health Initiative participants were followed up the date hospitalization through death or last participant contact before August 2009. DASH calculated food-frequency...

10.1161/circheartfailure.113.000495 article EN Circulation Heart Failure 2013-10-10

<h3>Background</h3> Elective bilateral salpingo-oophorectomy (BSO) is routinely performed with hysterectomy for benign conditions despite conflicting data on long-term outcomes. <h3>Methods</h3> This a prospective cohort of 25 448 postmenopausal women aged 50 to 79 years enrolled in the Women's Health Initiative Observational Study who had history and BSO (n = 14 254 [56.0%]) or ovarian conservation 11 194 [44.0%]) no family cancer. Multivariable Cox proportional hazards regression models...

10.1001/archinternmed.2011.121 article EN Archives of Internal Medicine 2011-04-25

Hypertension is a leading cause of global disease, mortality, and disability. While individuals African descent suffer disproportionate burden hypertension its complications, they have been underrepresented in genetic studies. To identify novel susceptibility loci for blood pressure people ancestry, we performed both single multiple-trait genome-wide association analyses. We analyzed 21 studies comprised 31,968 validated our results with additional 54,395 from multi-ethnic These analyses...

10.1371/journal.pgen.1006728 article EN public-domain PLoS Genetics 2017-05-12

Atrial fibrillation (AF) is the most common cardiac arrhythmia and associated with increased risk of stroke death. Obesity an independent factor for AF, but modifiers this are not well known. We studied roles obesity, physical activity, their interaction in conferring incident AF. The Women's Health Initiative (WHI) Observational Study was a prospective observational study 93 676 postmenopausal women followed average 11.5 years. Incident AF identified using WHI-ascertained hospitalization...

10.1161/jaha.114.001127 article EN cc-by-nc-nd Journal of the American Heart Association 2014-08-15

Investigating genetic architecture of complex traits in ancestrally diverse populations is imperative to understand the etiology disease. However, current paucity research people African and Latin American ancestry, Hispanic indigenous peoples United States likely exacerbate existing health disparities for many common diseases. The Population Architecture using Genomics Epidemiology, Phase II (PAGE II), Study was initiated 2013 by National Human Genome Research Institute expand our...

10.1371/journal.pone.0167758 article EN public-domain PLoS ONE 2016-12-14
Coming Soon ...